[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Grail Inc (GRAL)

Grail Inc (GRAL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,234,770
  • Shares Outstanding, K 41,020
  • Annual Sales, $ 147,170 K
  • Annual Income, $ -408,350 K
  • EBIT $ -534 M
  • EBITDA $ -371 M
  • 60-Month Beta 4.62
  • Price/Sales 14.49
  • Price/Cash Flow N/A
  • Price/Book 0.79

Options Overview Details

View History
  • Implied Volatility 101.29% (+0.36%)
  • Historical Volatility 75.70%
  • IV Percentile 74%
  • IV Rank 71.43%
  • IV High 114.97% on 05/13/25
  • IV Low 67.09% on 09/04/25
  • Expected Move (DTE 14) 8.03 (14.74%)
  • Put/Call Vol Ratio 1.73
  • Today's Volume 942
  • Volume Avg (30-Day) 956
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 20,229
  • Open Int (30-Day) 24,617
  • Expected Range 46.45 to 62.51

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-3.00
  • Number of Estimates 2
  • High Estimate $-2.92
  • Low Estimate $-3.08
  • Prior Year $-3.10
  • Growth Rate Est. (year over year) +3.23%

Price Performance

See More
Period Period Low Period High Performance
1-Month
44.06 +23.65%
on 04/10/26
55.88 -2.51%
on 04/27/26
+7.58 (+16.16%)
since 03/30/26
3-Month
41.50 +31.28%
on 02/23/26
109.35 -50.18%
on 02/03/26
-43.34 (-44.31%)
since 01/30/26
52-Week
29.95 +81.90%
on 08/20/25
118.84 -54.16%
on 01/22/26
+19.99 (+57.94%)
since 04/30/25

Most Recent Stories

More News
GRAIL to Present at the BofA Securities 2026 Health Care Conference

MENLO PARK, Calif. , April 30, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management...

GRAL : 54.48 (+9.64%)
GRAIL to Announce First Quarter 2026 Financial Results

MENLO PARK, Calif. , April 22, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue...

GRAL : 54.48 (+9.64%)
GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at 2026 ASCO Annual Meeting

Detailed NHS-Galleri Trial Results Will be Presented as a Late-Breaking Abstract in an Oral Presentation

GRAL : 54.48 (+9.64%)
GRAL DROPS ~50% -- REPORTED NUMBERS VS. ACTUAL RESULTS; LEVI & KORSINSKY, LLP INVESTIGATES

Grail told investors cash burn would be no more than $290 million while guiding to milestones the Company may have known were at risk

GRAL : 54.48 (+9.64%)
GRAIL Announces Integration of the Galleri® Test into Epic Electronic Health Record Platform to Expand Access Nationwide

Integration Will Enable Approximately 450 Health Systems to Access the Galleri Test Results Within Their Existing Patient Portal

GRAL : 54.48 (+9.64%)
GRAL Investors Have Opportunity to Join GRAIL, Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of GRAIL, Inc. (“GRAIL” or “the Company”) (NASDAQ:...

GRAL : 54.48 (+9.64%)
Cancer Is Striking Earlier -- Superpower and GRAIL Are Partnering to Expand Early Detection

Partnership expands access to breakthrough blood-based cancer screening into Superpower's comprehensive health check and personalized plans.

GRAL : 54.48 (+9.64%)
GRAL DROPS ~50% -- REPORTED NUMBERS VS. ACTUAL RESULTS; LEVI & KORSINSKY, LLP INVESTIGATES

Grail told investors cash burn would be no more than $290 million while guiding to milestones the Company may have known were at risk

GRAL : 54.48 (+9.64%)
GRAL DROPS ~50% -- REPORTED NUMBERS VS. ACTUAL RESULTS; LEVI & KORSINSKY, LLP INVESTIGATES

Grail told investors cash burn would be no more than $290 million while guiding to milestones the Company may have known were at risk

GRAL : 54.48 (+9.64%)
Stocks Sharply Lower on Iran War and Hawkish Powell

The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed down -1.36%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -1.63%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.43%. March...

MSTR : 165.45 (+4.59%)
GOOGL : 384.80 (+9.96%)
AAPL : 271.35 (+0.44%)
HL : 18.02 (+3.15%)
CDE : 17.97 (+3.69%)
GLXY : 27.44 (+7.95%)
LITE : 902.32 (+5.13%)
COIN : 187.77 (+3.32%)
TSLA : 381.63 (+2.37%)
SBUX : 105.33 (-0.16%)
SCCO : 171.69 (+1.94%)
^BTCUSD : 77,239.16 (+1.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Weakening short term outlook on maintaining the current direction.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

GRAIL LLC is a biotechnology company. It focuses on developing technologies for early cancer detection. GRAIL LLC is based in Menlo Park, United States.

See More

Key Turning Points

3rd Resistance Point 60.05
2nd Resistance Point 57.29
1st Resistance Point 55.89
Last Price 54.48
1st Support Level 51.73
2nd Support Level 48.97
3rd Support Level 47.57

See More

52-Week High 118.84
Fibonacci 61.8% 84.88
Fibonacci 50% 74.39
Fibonacci 38.2% 63.91
Last Price 54.48
52-Week Low 29.95

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.